VANESSA LICKSON: Open Payments
NPI 1609343698 · BLOUNTSTOWN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 36 payments from 21 companies in 2025. Trend: 2023 $286 · 2024 $296 · 2025 $970
Food & beverage: $963Education: $8
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 3 | $256 |
| Novo Nordisk Inc | 5 | $176 |
| Verona Pharma, Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $58 |
| Abbott Laboratories | 2 | $46 |
| Alexion Pharmaceuticals, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Medtronic, Inc. | 2 | $33 |
| Madrigal Pharmaceuticals | 1 | $27 |
Products named: Yorvipath, Wegovy, Ohtuvayre, MOUNJARO, FREESTYLE LIBRE 3, STRENSIQ, AIRSUPRA, TRIPTODUR.
Industry payments across FL — which companies pay providers there.
